{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T06:29:50Z","timestamp":1744784990993},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,5]]},"DOI":"10.18632\/oncotarget.7909","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T10:44:13Z","timestamp":1457088253000},"page":"18694-18704","source":"Crossref","is-referenced-by-count":11,"title":["Suppression of B-Raf(V600E) cancers by MAPK hyper-activation"],"prefix":"10.18632","volume":"7","author":[{"given":"Rawan","family":"Atiq","sequence":"first","affiliation":[{"name":"Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hertz","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Eldad","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Smeir","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Bar-Tana","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"McMahon","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.1008990107","article-title":"The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner","volume":"107","author":"Bollag","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.3392","article-title":"Tumor adaptation and resistance to RAF inhibitors","volume":"19","author":"Solit","year":"2013","journal-title":"Nat Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature10662","article-title":"RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)","volume":"480","author":"Tadi","year":"2011","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"Murray","year":"2010","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.0900780106","article-title":"(V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway","volume":"106","author":"Rosen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"McArthur","year":"2010","journal-title":"Nature"},{"key":"8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/2159-8290.CD-12-0531","article-title":"Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas","volume":"3","author":"Fagin","year":"2013","journal-title":"Cancer Discov"},{"key":"9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","article-title":"EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib","volume":"2","author":"Wargo","year":"2012","journal-title":"Cancer Discov"},{"key":"10","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2013.32","article-title":"Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas","volume":"133","author":"Cui","year":"2013","journal-title":"J Invest Dermatol"},{"key":"11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-12-0386","article-title":"Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma","volume":"3","author":"Larkin","year":"2013","journal-title":"Cancer Discov"},{"key":"12","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","article-title":"MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors","volume":"72","author":"Engelman","year":"2012","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","article-title":"Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K","volume":"18","author":"D'Andrea","year":"2010","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"key":"15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1101\/gad.186965.112","article-title":"Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy","volume":"26","author":"Morrison","year":"2012","journal-title":"Genes Dev"},{"key":"16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death\u2014apoptosis, autophagy and senescence","volume":"277","author":"Chambard","year":"2010","journal-title":"FEBS J"},{"key":"17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11515-014-1299-x","article-title":"Growth arrest signaling of the Raf\/MEK\/ERK pathway in cancer","volume":"9","author":"Park","year":"2014","journal-title":"Front Biol (Beijing)"},{"key":"18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Peeper","year":"2005","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Thompson","year":"2005","journal-title":"Mol Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jm00129a010","article-title":"Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids","volume":"32","author":"Witte","year":"1989","journal-title":"J Med Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bcp.2008.08.028","article-title":"AMPK activation by long chain fatty acyl analogs","volume":"76","author":"Hertz","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"22","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1158\/0008-5472.CAN-14-0385","article-title":"Long-chain fatty acid analogues suppress breast tumorigenesis and progression","volume":"74","author":"Bar-Tana","year":"2014","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1074\/jbc.M109.080416","article-title":"Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs","volume":"285","author":"Bar-Tana","year":"2010","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1096\/fj.06-7859rev","article-title":"Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival","volume":"22","author":"Westermarck","year":"2008","journal-title":"FASEB J"},{"key":"25","doi-asserted-by":"crossref","first-page":"37497","DOI":"10.1074\/jbc.M211739200","article-title":"Constitutive induction of p-Erk1\/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence","volume":"278","author":"Lim","year":"2003","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s11064-007-9394-x","article-title":"Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides","volume":"32","author":"Coppa","year":"2007","journal-title":"Neurochem Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.cellsig.2008.08.006","article-title":"ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling","volume":"20","author":"Frank","year":"2008","journal-title":"Cell Signal"},{"key":"28","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1038\/sj.onc.1209737","article-title":"Cisplatin induces PKB\/Akt activation and p38(MAPK) phosphorylation of the EGF receptor","volume":"25","author":"Levitzki","year":"2006","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cyto.2013.04.006","article-title":"Met\/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes","volume":"62","author":"Matsumoto","year":"2013","journal-title":"Cytokine"},{"key":"30","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","article-title":"Therapeutic destruction of insulin receptor substrates for cancer treatment","volume":"73","author":"Levitzki","year":"2013","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/MCB.17.11.6508","article-title":"STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation","volume":"17","author":"Blenis","year":"1997","journal-title":"Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2443.2011.01575.x","article-title":"Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45","volume":"17","author":"Nakajima","year":"2012","journal-title":"Genes Cells"},{"key":"33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-005-3089-x","article-title":"Protein phosphatase type 2A, PP2A, is involved in degradation of gp130","volume":"269","author":"Kikuchi","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2009.06.013","article-title":"FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST","volume":"35","author":"Lu","year":"2009","journal-title":"Mol Cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/MCB.01612-05","article-title":"Focal adhesion kinase controls cellular levels of p27\/Kip1 and p21\/Cip1 through Skp2-dependent and -independent mechanisms","volume":"26","author":"Pumiglia","year":"2006","journal-title":"Mol Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature11814","article-title":"Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance","volume":"494","author":"Stuart","year":"2013","journal-title":"Nature"},{"key":"37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Bajpe","year":"2014","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/MCB.17.9.5598","article-title":"Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1","volume":"17","author":"McMahon","year":"1997","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.187252.112","article-title":"Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis","volume":"26","author":"Peeper","year":"2012","journal-title":"Genes Dev"},{"key":"40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cellsig.2010.07.004","article-title":"Jailbreak: oncogene-induced senescence and its evasion","volume":"23","author":"Turner","year":"2011","journal-title":"Cell Signal"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:10:39Z","timestamp":1589224239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,5]]}},"alternative-id":["7909","26959890"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7909","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}